ページ3 - 最高のリンパ腫化学療法医師 - トップ72名の医師

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

ハダサ医療センターの血液学部門の責任者
教授

専門分野

• 血液学的疾患の分子診断
• 悪性血液疾患
• 骨髄移植
• 遺伝子治療
• 免疫学

キャリアの初めに、ディナ・ベン・イェフダはネゲブのベン・グリオン大学の医学部に入学しました。

ニューヨークのメモリアル・スローン・ケタリング癌センターで3年間の大学院研修の後、1992年にディナ・ベン・イェフダはハダサに戻りました。

2000年4月には、教授は血液学部門のディレクターに任命されました。

2017年、ベン・イェフダ教授はハダサ医学校の23代目の学部長となり、70年以上の歴史を持つ医療学部を率いる初の女性となりました。

ディナ・ベン・イェフダ教授は、戦闘中に戦死したまたは行方不明となった兵士に関する情報収集の取り組みで、参謀総長賞を受賞した初の女性兵士です。

最近、ディナ・ベン・イェフダはダニエル・ゾンネンフェルド基金から「Heart with the Heart受賞」を受賞しました。この名誉ある賞は、専門の枠を超えて患者に奉仕し、医学倫理以上のことを成し遂げた医師と看護師に与えられます。

専門協会への加入:

イスラエル血液学会

国際血液学会

イスラエル血液腫瘍学会

国際血液腫瘍学会

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Serdar Bedii Omay教授は、血液学および骨髄移植に関する65本以上の学術論文を発表しており、日本での研修経歴を持ちます。

• 日本の三重大学医学部にて血液学を専門に修得
• トルコ複数の大学にて血液学教授を歴任
• 血液学における36年の経験の診療経験
• 学会発表論文112編および学術会議発表34件の著者

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Education

• Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
• MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
• PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
• Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

Scientific Memberships

• Turkish Hematology Association
• Hematology Specialty Society
• Turkish Internal Medicine Specialty Society
• European Society of Hematology
•  

Awards 

• Young Researcher Award (42nd National Hematology Congress), 2016
• Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
• Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016

Education

MSc Faculty of Medicine (ING) Hacettepe University 1991-1997
Specialization Department of Pediatrics Dicle Universityniversitesi 1997-2002
Minor Cerrahpaşa Faculty of Medicine Pediatric Hematology & Oncology Department Istanbul University 2006-2009
Bone Marrow Transplant Unit MP Göztepe Hospital 2012-2013

Experience

Assistant Professor
Afyon Kocatepe University/Faculty of Medicine/Internal Medical Sciences
2003-2009 Department/ÇDepartment of Pediatrics)

Assistant Professor
Istanbul University/Cerrahpaşa Faculty of Medicineltesi/Internal Medical Sciences
2006-2009 Department of Pediatrics)

Pediatric Hematology Specialist Diyarbakır Children's Hospital, Pediatric Hematology compulsory service 2009-2012
Transfer Ünitesi Assistant Hematology Specialist Private Medical Park Göztepe Hospital Bone Marrow Transplant Unit Assistant Responsible Pediatric Hematology Specialist
2012-2013

Assistant Professor
Akdeniz University / Faculty of Medicine / Department of Internal Medical Scienceslümü/Department of Pediatrics)
2013-2014

Assistant Professor Marmara University/Faculty of Medicine/Department of Internal Medical Sciences/Department of Pediatrics) 2014-2024

Scientific Memberships

Turkish Society of Hematology
Turkish Pediatric Hematology Association
Marmara Pediatric Association
Turkish Pediatric Society
Istanbul Medical Chamber
EBMT (European Bone Marrow Transplantation)

Medical Fields of Interest: 

Chronic Leukemia (Chronic Lymphocytes Leukemia/ Chronic Myeloid Leukemia) 

Chronic Myeloproliferative Diseases (Polistemia Vera, Essential Thrombocytosis, Myelofibrosis etc.) 

Lymphoma (Hodgkin’s and Non-Hodgkin’s) 

Multiple Myeloma 

Education: 

Ege University Faculty of Medicine Medical Doctor 1999 - 2005 

Pamukkale University Specialist in Internal Medicine 2006 - 2011 

Pamukkale University Hematologist 2011 - 2014 

ESCCA Summer School On Cytometry/PRAGUE (May 2014) 

Istanbul Training and Research Hospital Hematology Clinic Associate Professor 2018 

Experience: 

Selçuk University Faculty of Medicine Hospital 2015 

Pamukkale University Internal Medicine Residency Training 2016 - 2011 

Denizli Sarayköy State Hospital 2011 - 2011 

Pamukkale University Hematology Minor Residency Training 2011 - 2014 

Istanbul Training and Research Hospital Hematology Clinic Specialist Doctor 2015 - 2020 

Istanbul Training and Research Hospital Hematology Clinic Responsible Authority 2015 - 2020 

Istanbul Training and Research Hospital Hematology Clinic Responsible Authority/ Lecturer 2019 - 2020 

Istanbul Başakşehir Çam and Şakura City Hospital Hematology Clinic Lecturer 2020 - 2020

Liv Hospital Ulus 2020-

Memberships: 

Turkish Society of Hematology 

The Society of Hematological Education and Research (Member of The Board of Directors

Publications:

32 articles published in international peer-reviewed journals 

12 cases published in international peer-reviewed journals 

11 articles published in national peer-reviewed journals 

5 cases published in national peer-reviewed journals

経歴と教育

ベイタン教授は1992年にアンカラ大学医学部を卒業し、ウルドゥグ大学医学部児童疾患学科で医学の専門家となりました。2002年には、同じ機関で小児血液学の助教授として働きました。

彼はまた、小児がん、白血病（リンパ腫）、小児出血性疾患の治療、血管閉塞、貧血治療、鉄欠乏症およびビタミン欠乏症の治療などの診断と治療に特化しています。

学術経験

ベイタン教授は、国際査読付きジャーナルに発表された15の論文、国際科学会議で発表および出版された9つの全文、地方/外国語で書かれた3つの書籍/書籍の章、地方査読付きジャーナルに公開された8つの論文を有しています。

医師はShyam Shah Medical Collegeで内科の医学博士号を取得し、同部門でシニアレジデンシーを務めました。その後、Jawaharlal Nehru Cancer Hospitalで医療腫瘍学のレジストラとして勤務しました。医師はIndraprastha Apollo Hospitalで医療腫瘍学のDNBトレーニングを修了しました。

シニアレジデンシーの期間中、医師はAIIMSで開催されたInternational Winter School of Oncologyで講義を行い、American Society of Clinical OncologyによるGastrointestinal Cancer Symposiumで胃がんに関する研究を発表しました。医師はがんの分子基盤と標的療法を専門としています。

ブランカ・ロペス・イボール・アリーニョ博士は、スペイン出身の小児血液腫瘍学の経験豊富な専門家であり、国内でトップクラスの小児神経外科医の一人でもあります。重篤な血液および癌疾患を有する子供とティーンエイジャーのケアに重点を置くHMグループの血液・小児腫瘍ユニットを率いています。ロペス・イボール博士は30年以上の実務経験を持ち、WHOおよびユネスコのコンサルタントとして働いています。教育および研究活動を提供しています。

ブランカ・ロペス・イボール博士の専門分野

医師は、特に赤血球、骨髄系、およびリンパ系の診断に関連する血液学的および癌性疾患の診断と治療を専門としています。イボール博士が治療する全ての疾患プロフィールを見るには、下にスクロールしてください。

教育

• マドリード・コンプルテンセ大学（スペイン） — 小児科および新生児ケアの医学学位
• バルセロナ大学（スペイン） — 医学のポストドクトラル学位
• メリーランド大学（アメリカ合衆国） — 小児腫瘍専門医および血液専門医。

職歴

• HM Hospitalesの血液・小児腫瘍ユニットの責任者 — 2006年から
• サン・ラファエル病院の血液・小児腫瘍部門の責任者 — 1999-2006
• ラ・サルスエラ大学病院の医師 — 1994-1999
• カタルーニャ総合大学病院の助手医師 — 1988-1993
• ニーニョ・ヘスス児童大学病院の助手医師 — 1986-1987

その他の活動

ロペス・イボール博士は2004年からスペイン保健省の小児がんの専門家として活躍しています。

ブランカ・ロペス・イボール博士は、マドリード・コンプルテンセ大学およびCEUサン・パブロ大学で講師を務めています。

医師は次を率いています：

• ハイメ・アロンソ・アブルーニャ基金 — 重篤な健康問題を抱える子供たちを支援することに重点を置いている基金。
• Curarte 基金 — 治療中の子供たちの生活の質を向上させる組織。

組織への所属

• アメリカ血液学会 (ASH)
• アメリカ小児血液腫瘍学会
• 国際小児腫瘍学会 (SIOP)
• スペイン小児科学会。

Dr. ラリットは、PuneのMIMERでMBBSを取得し、名門のGMC PanajiでMSを取得しました。これに続いて、彼はコルカタのタタ医療センターで2年間、外科腫瘍学のフェローシップを追求し、消化器癌に特に重点を置いたオンコサージェリーの訓練を受けました。彼はコルカタのタタ医療センターでいくつかのオリジナル研究の共同主任研究者として働きました。TMC、コルカタの後、彼は国立癌研究所およびオーランガバード政府癌病院の准教授を務めました。彼の豊富な10年間の外科経験で、彼は10,000以上の大手術を成功させました。彼は多くの国内外の出版物を持っています。彼の主な関心は、優れた結果をもたらす低侵襲癌手術にあります。彼は患者に親しみやすく倫理的なアプローチで知られています。 

Education

• Faculty of Medicine - Cerrahpaşa Faculty of Medicine 1999-2005
• Internal Medicine Residency - Istanbul Haseki Training and Research Hospital 2006-2010
• Hematology Subspecialist Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital - Hematology and Stem Cell Transplant Clinic 2013-2017
• Associate ProfessorIstanbul Ümraniye Training and Research Hospital 2019
•  

Experience

• Assistant Doctor Istanbul Haseki Training and Research Hospital - Internal Medicine Clinic 2006-2010
• Internal Medicine Specialist Istanbul Esenyurt State Hospital 2010-2012
• Internal Medicine Specialist-Military service Samsun Military Hospital 2012-2013
• Subspecialty Training Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital - Hematology and Stem Cell Transplant Clinic 2013-2017
• Hematology Subspecialist Ankara Gülhane Training and Research Hospital, Hematology and Stem Cell Transplant Clinic 2017-2018
• Hematology Subspecialist Istanbul Ümraniye Training and Research Hospital/Hematology 2018-2019
• Associate Professor Istanbul Ümraniye Training and Research Hospital/Hematology 2019-2021
• Associate Professor Maltepe University Faculty of Medicine / Hematology 2021-2024
• Associate Professor Istanbul VM Medical Park Pendik Hospital / Hematology and Stem Cell Transplant Clinic 2022-2024
•  

Scientific Memberships

• Turkish Medical Association
• Turkish Apheresis Society
• Hematologic Oncology Society
• Blood and Bone Marrow Transplant Association
• Hematologic Immunology Society
•  

Awards

•  
• Hematologic Oncology Society, 2015 - Second Prize for Paper
• Hematologic Oncology Society, 2016 - Second Prize for Paper
• Turkish Apheresis Association, 2016 - Paper Third Prize,
• Hematologic Immunology Association, 2016 - Second Prize for Paper
• Hematologic Oncology Society, 2016 - Second Prize for Paper
• Blood and Bone Marrow Transplantation Association, 2017 - First Prize for Paper
   

医師は、HCG Manavata Cancer Centre, Nashikで13年以上の経験を持つ非常に経験豊富な血液腫瘍学者であり、白血病、多発性骨髄腫、骨髄移植において専門知識を持っています。 <\/p>

Grant Medical CollegeおよびSir JJ HospitalでMBBSの学位を取得した後、医師はLokmanya Tilak Municipal Medical College, SionおよびMumbaiで病理学のMDを追求しました。 <\/p>

さらに、医師はMedical College, Calcuttaで臨床血液学のDMを取得し、プロフェッショナリズムと勤勉さで賞を受け、熟練した有能な専門家としての評判を強調しています。<\/p>

医師はムンバイのTata Memorial Hospitalで外科腫瘍学の訓練を受け、エディンバラのRoyal College of SurgeonsでMRCSを修了しました。2000年に実践を開始し、2007年にCurie Manavata Cancer Centreを設立しました。19年の経験を持ち、医師は50,000件以上の癌手術を行い、200以上の臨床試験に参加しました。医師は多くの国際的および国内の出版物を持つ著者です。乳房および胸部外科腫瘍学を専門とし、医師はMUHSでDNB Superspecialty Surgical OncologyおよびBreast Surgeryの教授です。<\/p>

Dr. Itir Sirinoglu Temiz is a Professor of Hematology. She specializes in lymphoma, acute and chronic leukemias, multiple myeloma, thrombocytopenias, thrombosis, anemia, and bone marrow failure. She graduated with honors from Istanbul University Cerrahpaşa Faculty of Medicine. She completed her hematology training at Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital.

Dr. Sirinoglu Temiz has held key academic and administrative positions. She served as Head of Internal Medicine at IAU Faculty of Medicine. She was also Education and Administrative Manager at SBÜ Bakırköy Dr. Sadi Konuk EAH Hematology Clinic. She has broad experience in adult hematology, stem cell transplantation, and therapeutic apheresis. She currently practices at Liv Hospital.